Development and validation of a mass spectrometric method to determine the identity of rituximab based on its microheterogeneity profile....

Taking advantage of a high-throughput flow cytometer for the implementation of an ADCC assay for regulatory compliance. VER MÁS

Characterization of a Complex Mixture of Immunomodulator Peptides Obtained from Autologous Urine. VER MÁS

Transcriptome-based identification of lovastatin as a breast cancer stem cell-targeting drug. VER MÁS

Progress and Challenges in the Design and Clinical Development of Antibodies for Cancer Therapy. VER MÁS